Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127371431 | 12737143 | 1 | I | 20160820 | 20160905 | 20160913 | 20160913 | EXP | CH-SM-2016-07074 | CH-SA-2016SA164812 | AVENTIS | 75.00 | YR | E | M | Y | 75.00000 | KG | 20160913 | MD | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127371431 | 12737143 | 1 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | UNK | 20839 | 300 | MG | FILM-COATED TABLET | |||||||
| 127371431 | 12737143 | 2 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | UNK | 20839 | 75 | MG | QD | |||||||
| 127371431 | 12737143 | 3 | I | XARELTO | RIVAROXABAN | 1 | Oral | Y | UNK | 0 | 20 | MG | QD | ||||||
| 127371431 | 12737143 | 4 | SS | ASPIRINE | ASPIRIN | 1 | Intravenous drip | UNK | 0 | 250 | MG | ||||||||
| 127371431 | 12737143 | 5 | SS | ASPIRINE | ASPIRIN | 1 | Oral | UNK | 0 | 100 | MG | QD | |||||||
| 127371431 | 12737143 | 6 | C | ENTRESTO | SACUBITRILVALSARTAN | 1 | Oral | 0 | 100 | MG | BID | ||||||||
| 127371431 | 12737143 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 80 | MG | QD | ||||||||
| 127371431 | 12737143 | 8 | C | TORASEMIDE | TORSEMIDE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 127371431 | 12737143 | 9 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 50 | MG | BID | ||||||||
| 127371431 | 12737143 | 10 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127371431 | 12737143 | 1 | Coronary arterial stent insertion |
| 127371431 | 12737143 | 2 | Coronary arterial stent insertion |
| 127371431 | 12737143 | 3 | Atrial fibrillation |
| 127371431 | 12737143 | 4 | Coronary arterial stent insertion |
| 127371431 | 12737143 | 5 | Coronary arterial stent insertion |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127371431 | 12737143 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127371431 | 12737143 | Cerebral haemorrhage | |
| 127371431 | 12737143 | Hemiparesis | |
| 127371431 | 12737143 | Potentiating drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127371431 | 12737143 | 1 | 20160820 | 20160820 | 0 | |
| 127371431 | 12737143 | 2 | 20160821 | 20160823 | 0 | |
| 127371431 | 12737143 | 3 | 20160823 | 0 | ||
| 127371431 | 12737143 | 4 | 20160820 | 20160820 | 0 | |
| 127371431 | 12737143 | 5 | 20160821 | 20160823 | 0 | |
| 127371431 | 12737143 | 6 | 20160719 | 20160820 | 0 | |
| 127371431 | 12737143 | 7 | 20160820 | 20160823 | 0 | |
| 127371431 | 12737143 | 8 | 20160823 | 0 | ||
| 127371431 | 12737143 | 9 | 20160821 | 20160823 | 0 | |
| 127371431 | 12737143 | 10 | 20160822 | 20160823 | 0 |